Skip to main content
. 2016 Apr 28;21(2):324–332. doi: 10.1007/s10157-016-1270-z

Table 4.

Characteristics of responders and non-responders to I-HDF

Responders (n = 34) Non-responders (n = 34) P value Statistics
Delta frequency of intervention [IQR]a −4 [−8, −2] 1 [0, 1]
Age (years) 68.6 ± 10.7 63.6 ± 11.3 0.066 #
Male (%) 50.0 52.9 0.808 #
Diabetics (%) 38.2 26.4 0.299 ##
Vintage (years; median [IQR]) 4.0[2.0–8.8] 4.7[1.9–12.8] 0.605 ###
Dry weight (kg) 53.8 ± 9.3 55.6 ± 12.3 0.479 #
Serum albumin (g/dL) 3.55 ± 0.41 3.62 ± 0.36 0.453 #
Cardiovascular disease (%) 47.1 35.3 0.324 ##
Antihypertensive agent (%) 47.1 52.9 0.628 ##
Pressor agent (%) 38.2 14.7 0.028 *, ##
Predialysis SBP (mmHg) 136.2 ± 22.8 134.4 ± 23.7 0.751 #
Intradialytic SBP increment (mmHg) 6.9 ± 12.4 0.9 ± 9.8 0.029 *, #
Pulse rate at 35 min (beats/min) 70.3 ± 14.4 71.0 ± 11.0 0.821 #
Net UF (L/session) 2.46 ± 0.78 2.17 ± 0.68 0.106 #
cUFR (mL/h/kg) 20.6 ± 3.4 18.3 ± 4.6 0.032 *, #
Interdialytic weight gain (% of DW) 4.8 ± 1.1 4.0 ± 1.5 0.017 *, #
Membrane area (m2) 1.69 ± 0.28 1.67 ± 0.29 0.730 #
Hematocrit (%) 32.6 ± 4.1 32.2 ± 3.0 0.599 #
BUN (mg/dL) 59.6 ± 12.2 62.3 ± ±12.8 0.382 #
Urea reduction ratio (%) 71.9 ± 5.0 69.5 ± 7.1 0.123 #
Blood flow (mL/min) 200 [200–200] 200 [200–200] 0.987 ###
Session time (min) 239.1 ± 11.6 229.4 ± 22.0 0.017 *, #
Dialysate buffer (citrate/acetate) 17/17 15/19 0.808 ##

Values are given in mean ± SD in normally distributed, median [IQR interquartile range] in non-normally distributed and % for categorical variables

BV blood volume, cUFR corrected UFR in I-HDF (see text)

### Wilcoxon signed-test, ## Chi-square test, # t-test, * statistically significant

a(Interventions during I-HDF) − (interventions during HD)